First Time Loading...
A

Apeloa Pharmaceutical Co Ltd
SZSE:000739

Watchlist Manager
Apeloa Pharmaceutical Co Ltd
SZSE:000739
Watchlist
Price: 14.11 CNY 1.36% Market Closed
Updated: May 2, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
Apeloa Pharmaceutical Co Ltd

Wall Street analysts forecast Apeloa Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Apeloa Pharmaceutical Co Ltd is 21.17 CNY with a low forecast of 17.68 CNY and a high forecast of 25.2 CNY.

Lowest Forecast
Wall Street Target
17.68 CNY
25% Upside
Average Forecast
Wall Street Target
21.17 CNY
50% Upside
Highest Forecast
Wall Street Target
25.2 CNY
79% Upside
Lowest
Price Target
17.68 CNY
25% Upside
Average
Price Target
21.17 CNY
50% Upside
Highest
Price Target
25.2 CNY
79% Upside
Apeloa Pharmaceutical Co Ltd Competitors:
Price Targets
G
GTII
Green Thumb Industries Inc
33% Upside
CPH
Cipher Pharmaceuticals Inc
38% Upside
RVNC
Revance Therapeutics Inc
301% Upside
M
MEGA
Mega Lifesciences PCL
22% Upside
G
GTII
Green Thumb Industries Inc
33% Upside
CPH
Cipher Pharmaceuticals Inc
38% Upside
RVNC
Revance Therapeutics Inc
301% Upside
M
MEGA
Mega Lifesciences PCL
22% Upside
002020
Zhejiang Jingxin Pharmaceutical Co Ltd
12% Upside
B
053030
Binex Co Ltd
14% Upside
IOLCP
IOL Chemicals and Pharmaceuticals Ltd
34% Upside

Revenue
Forecast

Revenue Estimate
Apeloa Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Apeloa Pharmaceutical Co Ltd's revenue is 13%. The projected CAGR for the next 3 years is 11%.

13%
Past Growth
11%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Apeloa Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Apeloa Pharmaceutical Co Ltd's operating income is 21%. The projected CAGR for the next 3 years is 17%.

21%
Past Growth
17%
Estimated Growth
Estimates Accuracy
0%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Apeloa Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Apeloa Pharmaceutical Co Ltd's net income is 22%. The projected CAGR for the next 3 years is 17%.

22%
Past Growth
17%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Apeloa Pharmaceutical Co Ltd's stock price target?
Price Target
21.17 CNY

According to Wall Street analysts, the average 1-year price target for Apeloa Pharmaceutical Co Ltd is 21.17 CNY with a low forecast of 17.68 CNY and a high forecast of 25.2 CNY.

What is Apeloa Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
11%

For the last 8 years the compound annual growth rate for Apeloa Pharmaceutical Co Ltd's revenue is 13%. The projected CAGR for the next 3 years is 11%.

What is Apeloa Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
17%

For the last 8 years the compound annual growth rate for Apeloa Pharmaceutical Co Ltd's operating income is 21%. The projected CAGR for the next 3 years is 17%.

What is Apeloa Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
17%

For the last 8 years the compound annual growth rate for Apeloa Pharmaceutical Co Ltd's net income is 22%. The projected CAGR for the next 3 years is 17%.

ALPHA SPREAD
Join more than 133,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.